|
|
|
Dong M. Shin, M.D.
| NAME Dong M. Shin, M.D. |
POSITION TITLE Associate Professor of Medicine M.D. Anderson Cancer Center, Houston, TX. |
 |
| INSTITUTION AND LOCATION | DEGREE (if applicable) | YEAR(s) | FIELD OF STUDY |
| Yonsei University, Seoul, Korea | 1971 | Pre-Med | |
| Yonsei University, College of Medicine, Seoul, Korea | M.D. | 1975 | Medicine |
| Cook County Hospital, Chicago IL | Residency | 1985 | Internal Medicine |
| University of Texas M.D. Anderson Cancer Center, Houston, TX | Fellowship | 1988 | Medical Oncology |
Professional Experience
| 1985 - 1988 | University of Texas M.D. Anderson Cancer Center, Department of Medical Oncology; Fellow of Medical Oncology, Houston, TX |
| 1988 - 1989 | University of Texas M. D. Anderson Cancer Center, Department of Medical Oncology; Faculty Associate, Houston, TX |
| 1989 - 1991 | Clinical Instructor of Medicine, Houston, TX |
| 1991 - 1996 | University of Texas M. D. Anderson Cancer Center, Department of Medical Oncology, Section of Head, Neck and Thoracic Medical Oncology; Assistant Professor of Medicine, Houston, TX |
| 1997 - Present | University of Texas M. D. Anderson Cancer Center, Department of Medical Oncology, Section of Head, Neck and Thoracic Medical Oncology; Associate Professor of Medicine, Houston, TX |
Publications (pertaining to lung cancer and mesothelioma only)
Shin DM, Walsh GL, Swisher S, Wimberly A, Shin HJC, RO JY, Khuri FR, Lee JS, Hong WK, Khokhar AR, Perez-Soler R.
Antitumor activity of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally in patients with malignant pleural mesothelioma.
Proc 10th NCI-ECORT Symposium on New Drugs in Cancer Therapy, pp 172, 1998
Shin DM, Perez-Soler R, Siddik ZH, Murphy WK, Huber M, Lee JS, Khokhar AR, Hong WK.
Phase I clinical and pharmacological study of liposome-entrapped (L-NDDP) administered intrapleurally in patients with malignant pleural effusions.
Clin Cancer Res 3:373-379, 1997.
Shin DM, Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ, Hong WK, Komaki R, Lee JJ, Nesbitt JC, Pisters KMW, Putnam JB, Schea R, Walsh GL, Dolormente MM, Jan C-I, Martinez FD, Yen N, XU K, Stephens LC, McDonel IJ, Mukhopadhyay T, Cai D:
Retrovirus-mediated wild type p53 transfer to tumor of patients with lung cancer.
Nature Med 2:985-991, 1996.
Shin, DM Perez-Soler R, Donato NJ, Rosenblum MG, Zhang H-Z, Tornos C, Brewer H, Shah T, Chan JC, Thompson LB, Janus M, Lee JS, Hong WK, Murray JL.
Tumor epidermal growth factor receptor studies in patients with non-small cell lung cancer or head and neck cancer treated with monoclonal antibody RG83852.
J Clin Oncol 12:730-739, 1994.
Shin, DM Shin HJ, Grant G, Hong WK, and Pathak S:
Simultaneous amplification of epidermal growth factor receptor and multidrug resistence genes in a newly established lung cancer cell line.
Anticancer Research 11:241-248, 1991.